Skip to main content
Premium Trial:

Request an Annual Quote

Genome Insight CancerVision

Genome Insight has launched CancerVision, a whole-genome sequencing (WGS) test designed to provide medically meaningful information to guide personalized medicine for cancer patients. According to Genome Insight, CancerVision combines proprietary bioinformatic pipelines with a cancer patient's WGS data, offering medically relevant insights such as genetic variations, applicable clinical trials, tumor mutational burden, and inherited germline polymorphisms.